Risk Partners Life Sciences Roundtable 2024, thank you very much! Already for the 26.06.2025 >

Cologne Higher Regional Court finally provides clarification with current ruling
in the area of D&O direct litigation

A new exciting ruling from the world of D&O insurance. The proceedings dealt with the question of who bears the burden of proof if a company does not first take action against the managing director in an internal liability case, but instead takes direct action against the D&O insurer(s) (so-called direct action). This is possible if the defendant has assigned his/her indemnification claims against the D&O insurer to the company. But what happens in this case to the privileged distribution of the burden of proof under section 93 (2) sentence 2 AktG? The Cologne Higher Regional Court has now provided some clarity here.

How is it basically?

In the normal case of an internal liability case, the managing director must prove that he/she has fulfilled his/her duty if he/she is sued by the company for damages for an alleged breach of duty. This benefits the suing company, as this is associated with hurdles in practice (keyword: documentation - see also our webinar with Fides Technology) . This applies in particular if the breach of duty was not (allegedly) committed recently, but years ago and now leads to a claim via the statutory subsequent liability. In legal terms and in practice, the company therefore enjoys a considerable privilege with regard to documentation standards in many companies when it comes to the distribution of the burden of proof under Section 93 (2) sentence 2 AktG.

What has now been decided?

The uncertainty was whether the company would have to demonstrate and prove the breach of duty in the event of a direct action against the D&O insurer(s), which would make such direct proceedings considerably more difficult. As a result, the company would follow in the footsteps of the directors and inherit their disadvantages in terms of the burden of proof. 

The Cologne judges have now clarified that the same rules apply in direct proceedings against the D&O insurer(s) as in "classic" directors' and officers' liability proceedings. This means that the insurer must prove that the insured manager has fulfilled his duties. The insurer therefore takes on the role of the manager. 

The ruling (case no. 9 U 206/22) fundamentally strengthens the position of companies that want to take direct action against their D&O insurers. It therefore becomes more attractive not to take legal action against the responsible managing director, but directly against his insurer. The prerequisite, however, is that the managing director assigns his insurance claim to the company beforehand or, in other words, also relinquishes control over the proceedings. In addition to the transfer of control by the managing director concerned, there are other issues to consider, such as the effects specifically on public limited companies in the strict AG regime or disadvantages generally associated with the "direct action" with reference to insurance contractual obligations in the event of a claim, so that Risk Partners will continue to follow the developments surrounding the direct action intensively for our clients.  

Also read our other blog posts

Being Public

Risk Partners supports successful uplisting of Formycon AG to the Prime Standard

Congratulations to Formycon AG on its successful uplisting to the Prime Standard of Deutsche Börse on November 12, 2024! Welcome to the Prime Standard league: A new champion of life sciences and biosimilars has successfully made the step from the Scale segment. We proudly congratulate Enno Spillner, Dr. Caroline Redeker, Daniel Marquard and the entire Formycon AG team on this great success and another important milestone on their way to becoming a global champion in the field of biosimilars! Formycon AG has focused on

Read more "
Being Public

Risk Partners supports successful IPO of Steyr Motors AG

We congratulate Steyr Motors AG on its successful listing in the Scale Segment of the German Stock Exchange on October 30, 2024! Risk Partners had the honor to act as IPO underwriting advisor on this transaction. Our team, led by Florian Eckstein and Björn Stressenreuter, supported Steyr Motors AG in its IPO on the Frankfurt Stock Exchange. Our expertise and comprehensive support were focused on providing Steyr Motors with a safe and successful start on the capital markets. We would like to thank Julian Cassutti and Christoph Cerar from Steyr Motors

Read more "
Being Public

Global Integrity and Compliance Forum 2024 

𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗻𝘁𝗲𝗴𝗿𝗶𝘁𝘆 𝗮𝗻𝗱 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝗙𝗼𝗿𝘂𝗺 𝟮𝟬𝟮𝟮𝟰 "D&O and Co. - Plan B to cover personal liability!" Last Friday, Florian had the honor of taking part in the Global Integrity and Compliance Forum at the Ludwig-Maximilians-Universität in Munich. Under the motto "The RULE of LAW in the Era of Integrity & Compliance", international legal experts, company managers, in-house councils and compliance officers from all over the world gathered to discuss the future of good corporate governance in 2024. Key discussions and insights One of the

Read more "
Management

Research breakdown at Stockholm's Karolinska Institute: A cooling failure destroys cell cultures from decades of research

Research mishap at Stockholm's Karolinska Institute: A cooling failure destroys cell cultures from decades of research - can you insure against it? An incident that threatens your very existence, but which we would like to shed some light on from the perspective of an insurance broker specializing in life sciences. What happened? A cooling system at the Karolinska Institute in Stockholm, Sweden's most important medical research center, failed for five days. Biological material that had been collected over 30 years and, according to the institute, was unique in the world, was destroyed as a result. The material was stored in deep-freeze tanks in which the temperature

Read more "
Management

OLG Schleswig – Statute of Limitations for Liability Claims in the Case of Direct Claims in D&O Insurance

OLG Schleswig: Statute of limitations for liability claims in the case of direct claims in D&O insurance. There is a new, exciting verdict from the world of D&O insurance. Recently, we reported on the decision of the Higher Regional Court of Cologne in the context of the direct lawsuit. Now the Higher Regional Court of Schleswig has also made a groundbreaking decision. What was it about? The focus was on the question of the statute of limitations. However, it must be taken into account that the question of the statute of limitations in the event of a D&O claim is not trivial. On the one hand, there is the original claim for damages (statutory D&O liability

Read more "
Life Sciences

Finance Day 2024

Growth capital for biotechnology and life sciences - Finance Day 2024 A few days ago, Jutta and Florian from our team attended Finance Day 2024 at the analytica trade fair in Munich. The event once again offered exciting expert panels on current financing and capital market issues for life sciences companies. As the panels focused on three of our key consulting areas, namely life sciences, venture capital and IPOs, attending was of course a must for us as a specialist insurance broker. Our team was also very pleased to meet many of our partners and clients again.

Read more "